Cargando…

Prognostic value of lymphovascular invasion in Bismuth-Corlette type IV hilar cholangiocarcinoma

AIM: To assess the prognostic value of lymphovascular invasion (LVI) in Bismuth-Corlette type IV hilar cholangiocarcinoma (HC) patients. METHODS: A retrospective analysis was performed on 142 consecutively recruited type IV HC patients undergoing radical resection with at least 5 years of follow-up....

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Bei, Xiong, Xian-Ze, Zhou, Yong, Wu, Si-Jia, You, Zhen, Lu, Jiong, Cheng, Nan-Sheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2017
Materias:	Retrospective Cohort Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5643289/ https://www.ncbi.nlm.nih.gov/pubmed/29085213 http://dx.doi.org/10.3748/wjg.v23.i36.6685

Ejemplares similares

Lymphocyte to Monocyte Ratio Predicts Resectability and Early Recurrence of Bismuth-Corlette Type IV Hilar Cholangiocarcinoma
por: Peng, Dingzhong, et al.
Publicado: (2019)

Treatment of hilar cholangiocarcinoma of Bismuth-Corlette type III with hepaticojejunostomy
por: Lu, Bao-Chun, et al.
Publicado: (2013)

A simple scoring system to predict early recurrence of Bismuth–Corlette type IV perihilar cholangiocarcinoma
por: Peng, Ding-Zhong, et al.
Publicado: (2019)

Individualized preoperative planning using three-dimensional modeling for Bismuth and Corlette type III hilar cholangiocarcinoma
por: Zeng, Ning, et al.
Publicado: (2016)

Transhepatic hilar approach for Bismuth types III and IV perihilar cholangiocarcinoma with long-term outcomes
por: Xu, Xinsen, et al.
Publicado: (2021)

Clinical efficacy of gemcitabine and cisplatin-based transcatheter arterial chemoembolization combined with radiotherapy in hilar cholangiocarcinoma
por: Zheng, Wen-Heng, et al.
Publicado: (2019)

Elevated red blood cell distribution width predicts poor prognosis in hilar cholangiocarcinoma
por: Li, Bei, et al.
Publicado: (2017)

Surgery for Bismuth-Corlette Type 4 Perihilar Cholangiocarcinoma: Results from a Western Multicenter Collaborative Group
por: Ruzzenente, Andrea, et al.
Publicado: (2021)

Role of resection for Bismuth type IV hilar cholangiocarcinoma and analysis of determining factors for curative resection
por: Han, In Woong, et al.
Publicado: (2014)

Percutaneous intraductal radiofrequency ablation in the management of unresectable Bismuth types III and IV hilar cholangiocarcinoma
por: Wang, Yu, et al.
Publicado: (2016)

Palliative treatment with radiation-emitting metallic stents in unresectable Bismuth type III or IV hilar cholangiocarcinoma
por: Lu, Jian, et al.
Publicado: (2017)

Propensity-matched analysis of patients with intrahepatic cholangiocarcinoma or mixed hepatocellular-cholangiocarcinoma and hepatocellular carcinoma undergoing a liver transplant
por: Brandão, Ajacio Bandeira de Mello, et al.
Publicado: (2022)

Perineural invasion of hilar cholangiocarcinoma in Chinese population: One center’s experience
por: Li, Cheng-Gang, et al.
Publicado: (2020)

Elevated platelet distribution width predicts poor prognosis in hilar cholangiocarcinoma
por: Li, Bei, et al.
Publicado: (2020)

Clinical practice of basin-shaped hepaticojejunostomy following hilar resection of stage III/IV hilar cholangiocarcinoma
por: Li, Qi-jiong, et al.
Publicado: (2019)

Tailored eradication vs empirical bismuth-containing quadruple therapy for first-line Helicobacter pylori eradication: A comparative, open trial
por: Choi, Youn I, et al.
Publicado: (2019)

Effect of hepatic artery resection and reconstruction on the prognosis of patients with advanced hilar cholangiocarcinoma
por: Li, Yuan-Ming, et al.
Publicado: (2022)

Regional variation in routes to diagnosis of cholangiocarcinoma in England from 2006 to 2017
por: Zalin-Miller, Amy, et al.
Publicado: (2023)

Development of a model based on the age-adjusted Charlson comorbidity index to predict survival for resected perihilar cholangiocarcinoma
por: Pan, Yu, et al.
Publicado: (2023)

Diagnostic value of FIB-4, aspartate aminotransferase-to-platelet ratio index and liver stiffness measurement in hepatitis B virus-infected patients with persistently normal alanine aminotransferase
por: Tan, You-Wen, et al.
Publicado: (2017)

Cholecystectomy reduces subsequent cholangiocarcinoma risk in choledocholithiasis patients undergoing endoscopic intervention
por: Wang, Chi-Chih, et al.
Publicado: (2020)

High tumor mutation burden indicates a poor prognosis in patients with intrahepatic cholangiocarcinoma
por: Song, Jian-Ping, et al.
Publicado: (2022)

Postoperative morbidity adversely impacts oncological prognosis after curative resection for hilar cholangiocarcinoma
por: Liu, Zhi-Peng, et al.
Publicado: (2022)

Compliance with enhanced recovery after surgery predicts long-term outcome after hepatectomy for cholangiocarcinoma
por: Jongkatkorn, Chaowasaporn, et al.
Publicado: (2023)

Clinical value of extended lymphadenectomy in radical surgery for pancreatic head carcinoma at different T stages
por: Lyu, Shao-Cheng, et al.
Publicado: (2022)

Accurate resection of hilar cholangiocarcinoma using eOrganmap 3D reconstruction and full quantization technique
por: Cui, Da-Peng, et al.
Publicado: (2023)

Comparison analysis of left-side versus right-side resection in bismuth type III hilar cholangiocarcinoma
por: Lee, YouJin, et al.
Publicado: (2018)

Pre-hepatectomy type IV collagen 7S predicts post-hepatectomy liver failure and recovery
por: Ishii, Masatsugu, et al.
Publicado: (2020)

Baseline hepatocyte ballooning is a risk factor for adverse events in patients with chronic hepatitis B complicated with nonalcoholic fatty liver disease
por: Tan, You-Wen, et al.
Publicado: (2023)

Prognostic value of preoperative carcinoembryonic antigen/tumor size in rectal cancer
por: Cai, Du, et al.
Publicado: (2019)

Fascia- vs vessel-oriented lateral lymph node dissection for rectal cancer: Short-term outcomes and prognosis in a single-center experience
por: Zhao, Wei, et al.
Publicado: (2023)

Diagnostic value of elevated serum carbohydrate antigen 199 level in acute cholangitis secondary to choledocholithiasis
por: Mei, Yong, et al.
Publicado: (2018)

Prognostic value of glycated hemoglobin in colorectal cancer
por: Ferroni, Patrizia, et al.
Publicado: (2016)

Application value of mixed reality in hepatectomy for hepatocellular carcinoma
por: Zhu, Liu-Yang, et al.
Publicado: (2022)

Prognostic value of claudin 18.2 expression in gastric adenocarcinoma
por: Kayikcioglu, Erkan, et al.
Publicado: (2023)

Prognostic value of risk scoring systems for cirrhotic patients with variceal bleeding
por: Tantai, Xin-Xing, et al.
Publicado: (2019)

Resection of Hilar Cholangiocarcinoma
por: Strasberg, Steven M.
Publicado: (1998)

Nomograms and risk score models for predicting survival in rectal cancer patients with neoadjuvant therapy
por: Wei, Fang-Ze, et al.
Publicado: (2020)

Impact of perioperative transfusion in patients undergoing resection of colorectal cancer liver metastases: A population-based study
por: Long, Bo, et al.
Publicado: (2019)

Risk factors and prognostic value of acute severe lower gastrointestinal bleeding in Crohn’s disease
por: Yoon, Jiyoung, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_t6ih4qhrmj817g481k0rj44m00